MONDELEZ INTERNATIONAL INC-A (MDLZ) Fundamental Analysis & Valuation
NASDAQ:MDLZ • US6092071058
Current stock price
57.31 USD
+0.06 (+0.1%)
At close:
57.1149 USD
-0.2 (-0.34%)
After Hours:
This MDLZ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. MDLZ Profitability Analysis
1.1 Basic Checks
- In the past year MDLZ was profitable.
- MDLZ had a positive operating cash flow in the past year.
- In the past 5 years MDLZ has always been profitable.
- In the past 5 years MDLZ always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of MDLZ (3.43%) is better than 65.52% of its industry peers.
- MDLZ's Return On Equity of 9.49% is fine compared to the rest of the industry. MDLZ outperforms 72.41% of its industry peers.
- MDLZ has a Return On Invested Capital of 5.26%. This is in the better half of the industry: MDLZ outperforms 60.92% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for MDLZ is in line with the industry average of 6.78%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.43% | ||
| ROE | 9.49% | ||
| ROIC | 5.26% |
ROA(3y)5.7%
ROA(5y)5.47%
ROE(3y)14.7%
ROE(5y)13.89%
ROIC(3y)7.9%
ROIC(5y)7.13%
1.3 Margins
- MDLZ has a better Profit Margin (6.36%) than 81.61% of its industry peers.
- In the last couple of years the Profit Margin of MDLZ has declined.
- Looking at the Operating Margin, with a value of 9.48%, MDLZ is in the better half of the industry, outperforming 75.86% of the companies in the same industry.
- MDLZ's Operating Margin has declined in the last couple of years.
- The Gross Margin of MDLZ (28.38%) is better than 66.67% of its industry peers.
- In the last couple of years the Gross Margin of MDLZ has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.48% | ||
| PM (TTM) | 6.36% | ||
| GM | 28.38% |
OM growth 3Y-8.01%
OM growth 5Y-9.55%
PM growth 3Y-9.66%
PM growth 5Y-13.81%
GM growth 3Y-7.55%
GM growth 5Y-6.31%
2. MDLZ Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MDLZ is creating some value.
- The number of shares outstanding for MDLZ has been reduced compared to 1 year ago.
- MDLZ has less shares outstanding than it did 5 years ago.
- The debt/assets ratio for MDLZ is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 2.24 indicates that MDLZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
- MDLZ's Altman-Z score of 2.24 is in line compared to the rest of the industry. MDLZ outperforms 59.77% of its industry peers.
- The Debt to FCF ratio of MDLZ is 6.55, which is on the high side as it means it would take MDLZ, 6.55 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of MDLZ (6.55) is better than 68.97% of its industry peers.
- A Debt/Equity ratio of 0.77 indicates that MDLZ is somewhat dependend on debt financing.
- The Debt to Equity ratio of MDLZ (0.77) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 6.55 | ||
| Altman-Z | 2.24 |
ROIC/WACC0.7
WACC7.5%
2.3 Liquidity
- MDLZ has a Current Ratio of 0.59. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 0.59, MDLZ is doing worse than 85.06% of the companies in the same industry.
- A Quick Ratio of 0.39 indicates that MDLZ may have some problems paying its short term obligations.
- With a Quick ratio value of 0.39, MDLZ is not doing good in the industry: 80.46% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.59 | ||
| Quick Ratio | 0.39 |
3. MDLZ Growth Analysis
3.1 Past
- MDLZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.36%.
- The Earnings Per Share has been growing slightly by 2.19% on average over the past years.
- MDLZ shows a small growth in Revenue. In the last year, the Revenue has grown by 5.75%.
- Measured over the past years, MDLZ shows a small growth in Revenue. The Revenue has been growing by 7.71% on average per year.
EPS 1Y (TTM)-15.36%
EPS 3Y-0.68%
EPS 5Y2.19%
EPS Q2Q%10.77%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y6.96%
Revenue growth 5Y7.71%
Sales Q2Q%9.29%
3.2 Future
- The Earnings Per Share is expected to grow by 8.76% on average over the next years. This is quite good.
- The Revenue is expected to grow by 3.25% on average over the next years.
EPS Next Y5.9%
EPS Next 2Y8.58%
EPS Next 3Y8.28%
EPS Next 5Y8.76%
Revenue Next Year3.34%
Revenue Next 2Y3.22%
Revenue Next 3Y3.15%
Revenue Next 5Y3.25%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. MDLZ Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 19.63 indicates a rather expensive valuation of MDLZ.
- MDLZ's Price/Earnings ratio is in line with the industry average.
- MDLZ's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.95.
- With a Price/Forward Earnings ratio of 18.53, MDLZ is valued on the expensive side.
- MDLZ's Price/Forward Earnings ratio is in line with the industry average.
- MDLZ is valuated cheaply when we compare the Price/Forward Earnings ratio to 38.68, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.63 | ||
| Fwd PE | 18.53 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MDLZ is on the same level as its industry peers.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of MDLZ indicates a somewhat cheap valuation: MDLZ is cheaper than 60.92% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.74 | ||
| EV/EBITDA | 17.93 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- MDLZ has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.33
PEG (5Y)8.95
EPS Next 2Y8.58%
EPS Next 3Y8.28%
5. MDLZ Dividend Analysis
5.1 Amount
- MDLZ has a Yearly Dividend Yield of 3.50%.
- MDLZ's Dividend Yield is a higher than the industry average which is at 2.22.
- Compared to an average S&P500 Dividend Yield of 1.81, MDLZ pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
5.2 History
- The dividend of MDLZ is nicely growing with an annual growth rate of 10.23%!
- MDLZ has been paying a dividend for at least 10 years, so it has a reliable track record.
- MDLZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)10.23%
Div Incr Years12
Div Non Decr Years12
5.3 Sustainability
- 101.47% of the earnings are spent on dividend by MDLZ. This is not a sustainable payout ratio.
- MDLZ's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP101.47%
EPS Next 2Y8.58%
EPS Next 3Y8.28%
MDLZ Fundamentals: All Metrics, Ratios and Statistics
57.31
+0.06 (+0.1%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-03 2026-02-03/amc
Earnings (Next)04-28 2026-04-28/amc
Inst Owners88.57%
Inst Owner Change-0.19%
Ins Owners0.18%
Ins Owner Change5.01%
Market Cap73.56B
Revenue(TTM)38.54B
Net Income(TTM)2.45B
Analysts77.06
Price Target67 (16.91%)
Short Float %3.1%
Short Ratio3.73
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
Yearly Dividend1.91
Dividend Growth(5Y)10.23%
DP101.47%
Div Incr Years12
Div Non Decr Years12
Ex-Date03-31 2026-03-31 (0.5)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.76%
Min EPS beat(2)0.24%
Max EPS beat(2)1.28%
EPS beat(4)4
Avg EPS beat(4)4.31%
Min EPS beat(4)0.24%
Max EPS beat(4)10.18%
EPS beat(8)7
Avg EPS beat(8)5.06%
EPS beat(12)11
Avg EPS beat(12)5.53%
EPS beat(16)15
Avg EPS beat(16)5.46%
Revenue beat(2)0
Avg Revenue beat(2)-0.89%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-0.15%
Revenue beat(4)0
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-2.09%
Max Revenue beat(4)-0.15%
Revenue beat(8)0
Avg Revenue beat(8)-1.43%
Revenue beat(12)3
Avg Revenue beat(12)-0.47%
Revenue beat(16)7
Avg Revenue beat(16)0.45%
PT rev (1m)-1.46%
PT rev (3m)-2.66%
EPS NQ rev (1m)-0.34%
EPS NQ rev (3m)-22.97%
EPS NY rev (1m)-0.2%
EPS NY rev (3m)-3.51%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-1.83%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-0.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.63 | ||
| Fwd PE | 18.53 | ||
| P/S | 1.91 | ||
| P/FCF | 22.74 | ||
| P/OCF | 16.29 | ||
| P/B | 2.85 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.93 |
EPS(TTM)2.92
EY5.1%
EPS(NY)3.09
Fwd EY5.4%
FCF(TTM)2.52
FCFY4.4%
OCF(TTM)3.52
OCFY6.14%
SpS30.03
BVpS20.13
TBVpS-14.12
PEG (NY)3.33
PEG (5Y)8.95
Graham Number36.3681 (-36.54%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.43% | ||
| ROE | 9.49% | ||
| ROCE | 7.36% | ||
| ROIC | 5.26% | ||
| ROICexc | 5.48% | ||
| ROICexgc | 44.22% | ||
| OM | 9.48% | ||
| PM (TTM) | 6.36% | ||
| GM | 28.38% | ||
| FCFM | 8.39% |
ROA(3y)5.7%
ROA(5y)5.47%
ROE(3y)14.7%
ROE(5y)13.89%
ROIC(3y)7.9%
ROIC(5y)7.13%
ROICexc(3y)8.16%
ROICexc(5y)7.43%
ROICexgc(3y)63.45%
ROICexgc(5y)50.76%
ROCE(3y)10.65%
ROCE(5y)9.63%
ROICexgc growth 3Y21.26%
ROICexgc growth 5Y4.14%
ROICexc growth 3Y1.32%
ROICexc growth 5Y-3.02%
OM growth 3Y-8.01%
OM growth 5Y-9.55%
PM growth 3Y-9.66%
PM growth 5Y-13.81%
GM growth 3Y-7.55%
GM growth 5Y-6.31%
F-Score5
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 6.55 | ||
| Debt/EBITDA | 3.97 | ||
| Cap/Depr | 94.18% | ||
| Cap/Sales | 3.32% | ||
| Interest Coverage | 6.41 | ||
| Cash Conversion | 90.06% | ||
| Profit Quality | 131.99% | ||
| Current Ratio | 0.59 | ||
| Quick Ratio | 0.39 | ||
| Altman-Z | 2.24 |
F-Score5
WACC7.5%
ROIC/WACC0.7
Cap/Depr(3y)97.41%
Cap/Depr(5y)92.16%
Cap/Sales(3y)3.4%
Cap/Sales(5y)3.29%
Profit Quality(3y)93.68%
Profit Quality(5y)93.08%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.36%
EPS 3Y-0.68%
EPS 5Y2.19%
EPS Q2Q%10.77%
EPS Next Y5.9%
EPS Next 2Y8.58%
EPS Next 3Y8.28%
EPS Next 5Y8.76%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y6.96%
Revenue growth 5Y7.71%
Sales Q2Q%9.29%
Revenue Next Year3.34%
Revenue Next 2Y3.22%
Revenue Next 3Y3.15%
Revenue Next 5Y3.25%
EBIT growth 1Y-45.43%
EBIT growth 3Y-1.61%
EBIT growth 5Y-2.57%
EBIT Next Year34.18%
EBIT Next 3Y15.26%
EBIT Next 5Y13.29%
FCF growth 1Y-8.17%
FCF growth 3Y2.52%
FCF growth 5Y0.85%
OCF growth 1Y-8.07%
OCF growth 3Y4.92%
OCF growth 5Y2.63%
MONDELEZ INTERNATIONAL INC-A / MDLZ Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for MONDELEZ INTERNATIONAL INC-A?
ChartMill assigns a fundamental rating of 4 / 10 to MDLZ.
Can you provide the valuation status for MONDELEZ INTERNATIONAL INC-A?
ChartMill assigns a valuation rating of 4 / 10 to MONDELEZ INTERNATIONAL INC-A (MDLZ). This can be considered as Fairly Valued.
How profitable is MONDELEZ INTERNATIONAL INC-A (MDLZ) stock?
MONDELEZ INTERNATIONAL INC-A (MDLZ) has a profitability rating of 6 / 10.
How financially healthy is MONDELEZ INTERNATIONAL INC-A?
The financial health rating of MONDELEZ INTERNATIONAL INC-A (MDLZ) is 3 / 10.
How sustainable is the dividend of MONDELEZ INTERNATIONAL INC-A (MDLZ) stock?
The dividend rating of MONDELEZ INTERNATIONAL INC-A (MDLZ) is 6 / 10 and the dividend payout ratio is 101.47%.